
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2022 Financial Results | News
MISSISSAUGA, ON, May possibly 26, 2022 /PRNewswire/ – Covalon Technologies Ltd. (the “Organization” or “Covalon”) (TSXV: COV) (OTC: CVALF), an innovative healthcare systems corporation, will launch its Q2 Fiscal 2022 money results on Monday May well 30th, 2022, just before markets open. A convention phone and webcast to go over the financial benefits will be held on Monday Could 30th, 2022, at 9:00am EST.
To view, listen to, and participate in the reside webcast, please follow the hyperlink underneath:
https://produceredition.webcasts.com/starthere.jsp?ei=1551026&tp_vital=74c818f1fa
To pay attention and take part by means of the meeting simply call, please dial:
North American Toll-Absolutely free: 1-888-664-6392
Neighborhood (Toronto): 416-764-8659
Confirmation Number: 10020730
Members will be able to ask queries of Organization management in the course of the Q&A part of the meeting phone possibly by inquiring them on the get in touch with or by distributing them using the chat functionality on the webcast.
A recording of the call will be accessible by calling 1-888-390-0541 or 416-764-8677 and coming into the encore replay entry code 020730# until eventually June 13th, 2022. A recording of the contact will also be accessible on www.covalon.com beneath News & Gatherings on the Investors tab.
Copies of Covalon’s economical statements and MD&A can be received on SEDAR at www.sedar.com and beneath Sedar Filings on the Traders tab of Covalon’s website.
About Covalon
Covalon Technologies Ltd. is a researcher, developer, company, and marketer of patent-secured clinical solutions that enhance affected individual outcomes and preserve lives in the parts of sophisticated wound care, an infection administration and surgical techniques. Covalon leverages its patented medical technological innovation platforms and skills in two ways: (i) by producing products and solutions that are sold under Covalon’s identify and (ii) by producing and commercializing professional medical merchandise for other professional medical firms less than improvement and license contracts. The Firm is outlined on the TSX Undertaking Exchange, obtaining the image COV and trades on the OTQX Industry less than the image CVALF. To study additional about Covalon, go to our web site at www.covalon.com.
Neither TSX Venture Exchange nor its Regulation Expert services Company (as that expression is outlined in the procedures of the TSX Undertaking Trade) accepts accountability for the adequacy or accuracy of this release.
This news release consists of forward-looking statements which mirror the Firm’s present-day expectations regarding potential events. The forward-hunting statements are normally, but not often, identified by the use of terms these kinds of as “request”, “foresee”, “approach, “estimate”, “count on”, “intend” and statements that an event or final result “may well”, “will”, “must”, “could” or “could” occur or be realized and other very similar expressions. These ahead-wanting statements entail threat and uncertainties, which includes the issues in predicting item approvals, acceptance of and calls for for new goods, the impact of the items and pricing techniques of opponents, delays in producing and launching new products and solutions, the regulatory ecosystem, fluctuations in operating benefits, the impression and timing of COVID-19 on operating actions and sector situations, and other risks, any of which could trigger success, overall performance, or achievements to vary materially from the benefits reviewed or implied in the ahead-seeking statements. Several threats are inherent in the industry other people are extra precise to the Business. Traders must consult the Company’s ongoing quarterly filings for added information on risks and uncertainties relating to these forward-looking statements. Investors ought to not spot undue reliance on any forward-on the lookout statements. The Corporation assumes no obligation to update or alter any ahead-wanting statements whether or not as a final result of new details, more situations or or else.
Check out primary content material to download multimedia:https://www.prnewswire.com/information-releases/covalon-announces-conference-contact-to-explore-next-quarter-fiscal-2022-fiscal-outcomes-301555723.html
Supply Covalon Systems Ltd.